Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Prostate Cancer

  Free Subscription


29.09.2025

1 BJU Int
1 Br J Cancer
1 Br J Radiol
1 Clin Imaging
1 Eur Urol
1 Int J Urol
1 J Natl Cancer Inst
1 Lancet Oncol
3 Oncogene
1 Oncol Rep
2 PLoS One
1 Proc Natl Acad Sci U S A
6 Prostate
3 Radiol Imaging Cancer


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BJU Int

  1. VAN DEN EYNDE L, Ost P, Verla W, Everaerts W, et al
    Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer.
    BJU Int. 2025 Sep 20. doi: 10.1111/bju.70006.
    PubMed         Abstract available


    Br J Cancer

  2. CHANG YH, Bresnahan ST, Taylor Head S, Harrison TA, et al
    Isoform-level analyses of 6 cancers uncover extensive genetic risk mechanisms undetected at the gene-level.
    Br J Cancer. 2025;133:874-885.
    PubMed         Abstract available


    Br J Radiol

  3. LANDRY C, Klusa D, Cochonneau D, Supiot S, et al
    Circulating tumor cells for the prediction of the response to radiation therapy in prostate cancer.
    Br J Radiol. 2025 Sep 13:tqaf224. doi: 10.1093.
    PubMed         Abstract available


    Clin Imaging

  4. DEFFLER C, Sedeh AE, Leitman E, Ng TSC, et al
    The role of PSMA PET/CT in identifying benign and malignant intracranial lesions in patients with prostate cancer.
    Clin Imaging. 2025 Sep 12:110620. doi: 10.1016/j.clinimag.2025.110620.
    PubMed         Abstract available


    Eur Urol

  5. ENGLMAN C, Adebusoye B, Mallett S, Giganti F, et al
    Reply to Yuan Du, Dan Liu, and Zhihui Guan's Letter to the Editor re: Cameron Englman, Busola Adebusoye, Davide Maffei, et al. Magnetic Resonance Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort Stu
    Eur Urol. 2025 Sep 18:S0302-2838(25)00500-7. doi: 10.1016/j.eururo.2025.
    PubMed        


    Int J Urol

  6. MIYOSHI Y, Uemura H, Ohta J, Kobayashi K, et al
    Prognostic Value of BONENAVI Computer-Aided Diagnosis System Bone Scans as an Imaging Biomarker for Bone-Metastatic Castration-Sensitive Prostate Cancer: An Investigator-Initiated, Multicenter, Prospective Observational Study.
    Int J Urol. 2025 Sep 23. doi: 10.1111/iju.70214.
    PubMed         Abstract available


    J Natl Cancer Inst

  7. VERTOSICK EA, Vickers A, Dahlin A, Ulmert D, et al
    Prostate-specific antigen levels at age 60 and lifetime risk of lethal prostate cancer.
    J Natl Cancer Inst. 2025 Sep 19:djaf271. doi: 10.1093.
    PubMed         Abstract available


    Lancet Oncol

  8. GRUBER K
    Prostate cancer screening bill before NZ Parliament.
    Lancet Oncol. 2025 Sep 18:S1470-2045(25)00557.
    PubMed        


    Oncogene

  9. SHENG H, Shi G, Lu Y, Zheng S, et al
    KBTBD11 loss promotes AKT hyperactivation and therapeutic vulnerability in prostate cancer.
    Oncogene. 2025 Sep 23. doi: 10.1038/s41388-025-03576.
    PubMed         Abstract available

  10. GE Y, Han P, Sun Y, Chen Y, et al
    Aging-associated ZNF573 methylation regulates RNF19B-PIK3CA ubiquitination to promote prostate cancer.
    Oncogene. 2025 Sep 19. doi: 10.1038/s41388-025-03579.
    PubMed         Abstract available

  11. CHUKHU M, Dahiya UR, Heemers HV
    Evolving roles for the androgen receptor and its protein interactome in castration-resistant prostate cancer.
    Oncogene. 2025 Sep 18. doi: 10.1038/s41388-025-03573.
    PubMed         Abstract available


    Oncol Rep

  12. NAKAYAMA M, Takagi-Maeda S, Machino Y, Nihira K, et al
    Novel tetravalent bispecific antibody, PSMA/TRAIL?R2 REGULGENT, induces selective tumor cell apoptosis without hepatotoxicity.
    Oncol Rep. 2025;54:155.
    PubMed         Abstract available


    PLoS One

  13. HWANG J, Kang BH, Park Y, Choi DH, et al
    Improving segmentation precision in prostate cancer adaptive radiation therapy with a patient-specific network.
    PLoS One. 2025;20:e0332603.
    PubMed         Abstract available

  14. DAMKLIANG K, Thongsuksai P, Wongsirichot T, Kayasut K, et al
    Detection and score grading for prostate adenocarcinoma using semantic segmentation.
    PLoS One. 2025;20:e0331613.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  15. CHOWDHURY SR, Parikh CN, Kaur AN, DeMarco KD, et al
    PPT1 is a negative regulator of STING signaling in cancer cells and its inhibition reactivates immune surveillance in cold tumors.
    Proc Natl Acad Sci U S A. 2025;122:e2514948122.
    PubMed         Abstract available


    Prostate

  16. HOGGARD NK, Berg FM, Szczepaniak MR, Wang X, et al
    Pathology of a Canine Model of Localized Prostate Carcinoma.
    Prostate. 2025 Sep 22. doi: 10.1002/pros.70054.
    PubMed         Abstract available

  17. YANEZ-CASTILLO YM, Melgarejo-Segura MT, Arrabal-Polo MA, Jimenez-Pacheco A, et al
    Enhancing Prostate Cancer Diagnosis: The Combined Value of PHI and mpMRI.
    Prostate. 2025 Sep 22. doi: 10.1002/pros.70055.
    PubMed         Abstract available

  18. LI C, He C, Pan J, Feng Y, et al
    MIF Facilitates Resistance to Androgen Deprivation Therapy by Regulating AMPD2 Expression in Prostate Cancer Cells.
    Prostate. 2025 Sep 19. doi: 10.1002/pros.70053.
    PubMed         Abstract available

  19. PEINADO BRR, Nazario RMF, Frazao DR, Ne YGS, et al
    Is There Any Association Between Periodontitis and Prostatic Alterations? A Systematic Review.
    Prostate. 2025;85:1369-1385.
    PubMed         Abstract available

  20. SANDOVAL V, Osinski T, Malshy K, Feng C, et al
    Long-Term Oncological Outcomes of Robot-Assisted Radical Prostatectomy for Clinically Localized Grade Groups 4 and 5 Prostate Cancers Diagnosed on Prostate Biopsy.
    Prostate. 2025;85:1432-1439.
    PubMed         Abstract available

  21. BORQUE-FERNANDO A, Guerrero-Ochoa P, Esteban LM, Hernandez A, et al
    Integration of Primary Care Into the Follow-Up Protocol for Prostate Cancer Patients in Aragon, Spain. It Is Time to Follow Other Successful Models in the Region.
    Prostate. 2025 Sep 24. doi: 10.1002/pros.70057.
    PubMed         Abstract available


    Radiol Imaging Cancer

  22. GARG T, Wehrenberg-Klee E
    New Frontier for Prostate Artery Embolization: Neoadjuvant PAE before Radiation Therapy in Patients with Prostate Cancer.
    Radiol Imaging Cancer. 2025;7:e259023.
    PubMed        

  23. FIELDS BKK, Hassan OT
    An MRI Histopathology-based Deep Learning Approach for the Classification of Prostate Cancer.
    Radiol Imaging Cancer. 2025;7:e250466.
    PubMed        

  24. NGUYEN C, Hulsey G, James K, James T, et al
    Deep Learning Classification of Prostate Cancer Using MRI Histopathologic Data.
    Radiol Imaging Cancer. 2025;7:e240381.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.